About Us

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell ↗

Today 13:35 EST

Via The Motley Fool

Long Service Life Industrial Ceiling Fan HVLS in Factory with PMSM Motor

Today 12:45 EST

Via AB Newswire

CGTN: Why Xi Jinping chose a Beijing tech hub for his first domestic tour in 2026

Today 12:04 EST

Via Binary News Network

Light Up the Night: Introducing Custom RGB Acrylic LED Car Badges for the Ultimate Aftermarket Upgrade

Today 11:52 EST

Via AB Newswire

Magic and Marvel: Hasbro Stock Surges 7.9% as Wizards of the Coast Powers Historic Earnings Beat

Today 11:50 EST

Via MarketMinute

Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse

Today 10:26 EST

Via Finterra

BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Files Orphan Drug Designation Application for NV-387 as Measles Treatment

Today 10:25 EST

Via Investor Brand Network

The $80 Billion Ambition: An In-Depth Analysis of AstraZeneca (AZN) in 2026

Today 10:15 EST

Via Finterra

The Glass Architecture of AI: A Comprehensive Research Feature on Corning Inc. (GLW)

Today 9:59 EST

Via Finterra

Iranian-Born Engineer Mohsen Bahmani Introduces Propeller-Less Propulsion for Urban Air Mobility

Today 9:55 EST

Via PRLog

Should You Buy Vertex Before Feb. 12? ↗

Today 9:55 EST

Via The Motley Fool

The Backbone of AI: A Comprehensive Research Feature on Credo Technology Group (CRDO)

Today 9:44 EST

Via Finterra

The Vertical Integration of Wellness: A Deep Dive into Hims & Hers Health (HIMS)

Today 9:41 EST

Via Finterra

BioMedNewsBreaks — Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Michael Cola as Chief Executive Officer

Today 9:35 EST

Via Investor Brand Network

Eli Lilly Is Partnering with Gene-Editing Start-up Seamless Therapeutics. Here's What Investors Need to Know. ↗

Today 9:35 EST

Via The Motley Fool

Enertopia Announces CAPNTRACK and Hydrogen Update

Today 9:00 EST

Via Newsfile

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

Today 8:25 EST

Via FinancialNewsMedia

5 Revealing Analyst Questions From Merck’s Q4 Earnings Call

Today 0:36 EST

Via StockStory

The Top 5 Analyst Questions From Illinois Tool Works’s Q4 Earnings Call

Today 0:33 EST

Via StockStory

Mark Cuban Says Trade Secrets Are Going To Become More Common In The AI Age: Here's What The Billionaire Said ↗

February 09, 2026

Via Benzinga

Brooks Craft Publishing Reinforces Its Contribution to the Evolving Book Publishing Industry Through Author-Centered Services

February 09, 2026

Via AB Newswire

Hims & Hers Collapses After FDA Vows to Restrict Copycat GLP-1 Pill. Is the Stock Toast? ↗

February 09, 2026

Via The Motley Fool

The American Academy of Advanced Thinking Announces a Controversial Shift: It Will Measure Thinking Outcomes, Not Engagement

February 09, 2026

Via AB Newswire

AI Content Detection: Preserving Authenticity in the Age of Generative Intelligence

February 09, 2026

Via AB Newswire

Novo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment? ↗

February 09, 2026

Via The Motley Fool

Deepening Green Intelligent Manufacturing – Linyi Fulong Welcomes Central Asian Client Delegation, Empowering Global Layout

February 09, 2026

Via AB Newswire

Why This Analyst Just Slashed Their Price Target on Qualcomm Stock by 30%

February 09, 2026

Via Barchart.com

Should You Buy Pfizer's Stock for Its 6.3%-Yielding Dividend? ↗

February 09, 2026

Via The Motley Fool

World Association of Artists Opens WAA International Art Competition 2025-2026, Inviting Global Talent to a Borderless Stage

February 09, 2026

Via Get News

Hims & Hers Under Fire, Stock Tanks on Federal Crackdown, Patent War ↗

February 09, 2026

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.